Document is current
Any future updates will be listed below
-
Authors
Gong, Huan
Griffin, J. Daniel
Groer, Chad E.
Wu, Xiaoqing
Li, Mengyue
Abdelaziz, Moustafa M.
Xu, Liang
Forrest, Marcus Laird
Berkland, Cory J. https://orcid.org/0000-0002-7164-7886
-
Funding
Funding for this research was provided by:
Small Business Innovative Research and Small Business Technology Transfer (R41CA272024)
- License Information
-
More Information
Article History
Accepted: 14 January 2025
First Online: 29 January 2025
Declarations
:
: All institutional and national guidelines for the care and use of laboratory animals were followed. All rodent experiments, except the anti-mPD-L1 combination study, were conducted at the University of Kansas ACU, adhering to the Guide for the Care and Use of Laboratory Animals, and holding accreditation from the AAALAC. These experiments followed a protocol (No. 168-04) approved by the KU IACUC committee. The anti-mPD-L1 combination study was conducted by Reaction Biology (Europe GmbH). This animal study has been approved by the Ethics Committee for Animal Experimentation and was registered by the regional board Freiburg. Mice were handled according to the German animal welfare law and the GV-SOLAS guidelines. Health monitoring of the animal facility was done according to FELASA guidelines quarterly by examination of sentinel animals.
: The authors affirm that there was no data from human research participants in this publication.
: The authors declare the following competing financial interest(s): Daniel Griffin is a consultant and has ownership interest in Kinimmune. Cory J. Berkland has ownership interests in Kinimmune. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work presented in this paper.
